The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $70.95

Today's change-0.24 -0.34%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $70.95

Today's change-0.24 -0.34%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.

Magellan Health Inc down (U.S.)$0.24

Magellan Health Inc closed lower Monday, dropping (U.S.)$0.24 or 0.34% to (U.S.)$70.95. Over the last five days, shares are unchanged, but are currently 1.14% below its 52-week high. This security has outperformed the S&P 500 by 14.99% during the last year.

Key company metrics

  • Open(U.S.) $71.50
  • Previous close(U.S.) $71.19
  • High(U.S.) $71.55
  • Low(U.S.) $70.76
  • Bid / Ask(U.S.) $60.58 / (U.S.) $0.00
  • YTD % change+18.19%
  • Volume126,996
  • Average volume (10-day)121,443
  • Average volume (1-month)146,889
  • Average volume (3-month)152,430
  • 52-week range(U.S.) $52.37 to (U.S.) $71.77
  • Beta0.62
  • Trailing P/E24.38×
  • P/E 1 year forward29.66×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.91
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.97%

Based on its net profit margin of 1.97%, Magellan Health Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Managed Health Care
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue982923888966
Total other revenue--------
Total revenue982923888966
Gross profit61493571
Total cost of revenue922874853896
Total operating expense946898876916
Selling / general / administrative--------
Research & development--------
Depreciation / amortization24242220
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income36251251
Interest income (expense), net non-operating-2-3-2-1
Gain (loss) on sale of assets--------
Other--------
Income before tax35221150
Income after tax2026424
Income tax, total15-3626
Net income2227526
Total adjustments to net income--------
Net income before extra. items2227526
Minority interest2111
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2227526
Inc. avail. to common incl. extra. items2227526
Diluted net income2227526
Dilution adjustment--0----
Diluted weighted average shares26272828
Diluted EPS excluding extraordinary itemsvalue per share0.821.000.180.92
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.821.000.180.92